BioSpace News Archive

DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE: DYME)(OTCQB:DYMEF), a multi-state cannabis brands platform, announced today that it has signed a definitive agreement to acquire select assets from MM Esperanza 2 LLC, doing business as “MMAC,” and MMAC’s 1.83 acre Los Angeles cannabis campus.

The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA®) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019

Vohra Wound Care has been awarded a Health Care Quality Account grant by the Maryland Department of Health Office of Health Care Quality.

Stroke survivor Amy Walters will deliver the inaugural patient lecture and Dr. Andrew Molyneux will give the meeting’s Luminary Lecture

Vizient, Inc., today announced the product categories and supplier savings opportunities available as part of its Quarter 3 National Group Buys Program available July 1 through Sept. 30.

Dividend to be Paid on September 13, 2019

Acerus Pharmaceuticals Corporation announced that it has entered into a US$5 million subordinated secured term loan facility with First Generation Capital Inc., a company affiliated with the Chairman of the Board of Directors of Acerus.

Contract expanded to 2020 with ADL revenues anticipated to exceed EUR 12 million

Elekta (EKTA-B.ST) today announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has achieved regulatory certification from the Canadian Nuclear Safety Commission, clearing the technology for clinical use in Canada.

IDenta Corp. (OTCQB: IDTA) is a worldwide leader in the development of field Drug & Explosive detection kits and unique forensic products.